BioCryst Pharmaceuticals(BCRX) - 2024 Q1 - Earnings Call Transcript

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript May 6, 2024 8:30 AM ET Company Participants John Bluth - IR Jon Stonehouse - CEO Charlie Gayer - CCO Helen Thackray - Chief R&D Officer Anthony Doyle - CFO Conference Call Participants Maury Raycroft - Jefferies Tazeen Ahmad - Bank of America Serge Belanger - Needham & Company Liisa Bayko - Evercore ISI Stacy Ku - TD Cowen Gena Wang - Barclays Francois Brisebois - Oppenheimer Jon Wolleben - JMP Securities Chris Raymond - Piper San ...